- Open Access
Is bronchial thermoplasty safe in allergic bronchopulmonary aspergillosis or severe asthma with fungal sensitization?
BMC Pulmonary Medicine volume 21, Article number: 169 (2021)
We read with interest the case presented by Sasada et al., describing the occurrence of aspergillosis in a patient who underwent bronchial thermoplasty (BT) . The isolation of Aspergillus fumigatus, the presence of elevated serum total IgE, and possible eosinophilic inflammation (high FeNO) suggest allergic sensitization to A.fumigatus. However, the diagnosis remains unproven as specific IgE or skin test against A.fumigatus was not performed in the index case. The authors mention that there was a remarkable improvement after BT. With only two sessions of BT being completed, the observed improvement is likely the effect of itraconazole therapy. Itraconazole offers excellent results in patients with severe asthma with fungal sensitization (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) [2, 3]. The absence of bronchiectasis on computed tomography does not rule out ABPA and therefore, immunological investigations are required . The prevalence of Aspergillus sensitization is about 28% in asthmatics and maybe as high as 50% in those with severe asthma [5, 6].
There is a significant burden of fungal allergy in Japan. In a recent Japanese study of 124 subjects with SAFS, 29% had allergic sensitization to at least one fungus, and sensitization to A.fumigatus was seen in 11% . With such a high prevalence of fungal allergy in Japan, it would be reasonable to exclude SAFS or ABPA before BT. BT is a valuable addition in severe asthma management, especially for those who are not candidates for oral glucocorticoids or biologic therapy. Nevertheless, a thorough evaluation of coexisting conditions or complications is an indispensable component while evaluating severe asthma [8, 9]. Further, the trials evaluating BT or biologics in asthma have not included subjects with SAFS or ABPA. Hence, extrapolating the results beyond the trial population may be problematic. Thus, the index case should serve as a reminder to systematically evaluate severe asthma before contemplating treatment with newer modalities such as BT.
Availability of data and materials
Allergic bronchopulmonary aspergillosis
Severe asthma with fungal sensitization
Sasada S, Ohmura K, Oguri T, Fujimoto Y, Murata S, Tsuchiya Y, et al. A case report of aspergillosis accompanied by saccular bronchodilation after bronchial thermoplasty in a 19-year-old woman. Bmc Pulm Med. 2020;20(1):312.
Denning DW, O’droscoll BR, Powell G, Chew F, Atherton GT, Vyas A, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the fungal asthma sensitization trial (fast) study. Am J Respir Crit Care Med. 2009;179(1):11–8.
Agarwal R, Dhooria S, Singh Sehgal I, Aggarwal AN, Garg M, Saikia B, et al. A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Chest. 2018;153(3):656–64.
Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol. 2012;4(4):141–50.
Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009;13(8):936–44.
Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses. 2010;53(2):138–43.
Masaki K, Fukunaga K, Matsusaka M, Kabata H, Tanosaki T, Mochimaru T, et al. Characteristics of severe asthma with fungal sensitization. Ann Allergy Asthma Immunol. 2017;119(3):253–7.
Majellano EC, Clark VI, Winter NA, Gibson PG, Mcdonald VM. Approaches to the assessment of severe asthma: barriers and strategies. J Asthma Allergy. 2019;12:235–51.
Agarwal R, Gupta D. Severe asthma and fungi: current evidence. Med Mycol. 2011;49(Suppl 1):S150–7.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Muthu, V., Agarwal, R. Is bronchial thermoplasty safe in allergic bronchopulmonary aspergillosis or severe asthma with fungal sensitization?. BMC Pulm Med 21, 169 (2021). https://doi.org/10.1186/s12890-021-01535-1
- Cystic fibrosis
- Allergic bronchopulmonary mycosis